Smooth muscle-like tissues engineered with bone marrow stromal cells

被引:33
作者
Cho, SW
Kim, IK
Lim, SH
Kim, DI
Kang, SW
Kim, SH
Kim, YH
Lee, EY
Choi, CY
Kim, BS
机构
[1] Hanyang Univ, Dept Chem Engn, Seoul 133791, South Korea
[2] Seoul Natl Univ, Sch Chem Engn, Seoul 151742, South Korea
[3] Yonsei Univ, Coll Med, Div Cardiovasc Surg, Ctr Cardiovasc, Seoul 120752, South Korea
[4] Sungkyunkwan Univ, Div Vasc Surg, Samsung Med Ctr, Seoul 135230, South Korea
[5] Korea Inst Sci & Technol, Biomat Res Ctr, Seoul 130650, South Korea
[6] Kyungsung Univ, Dept Food Sci & Technol, Pusan 608736, South Korea
关键词
bone marrow stromal cells; smooth muscle; tissue engineering; biodegradable polymer scaffold;
D O I
10.1016/j.biomaterials.2003.09.068
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Bone marrow-derived cells have demonstrated the ability to differentiate into multiple mesenchymal cell lineages. Here we tested whether smooth muscle (SM)-like tissues can be created in vivo with bone marrow stromal cells (BMSCs). Cultured canine BMSCs, which expressed SM cell-specific markers including SM alpha-actin and SM myosin heavy chain, were seeded on three-dimensional, biodegradable polymer scaffolds and implanted into peritoneal cavity of athymic mice. The cell-scaffold constructs retrieved 4 weeks after implantation formed three-dimensional tissues. Inummohistochemical analyses showed that the tissue reconstructs expressed SM alpha-actin and SM myosin heavy chain. Masson's trichrome staining showed the presence of significant amounts of collagen in the tissue reconstructs. Cells labeled with a fluorescent tracer prior to implantation were still present in the tissue reconstructs 4 weeks after implantation. Non-seeded scaffolds (control groups) retrieved 4 weeks after implantation did not exhibit extensive tissue formation. This study demonstrates the potential of BMSCs as an alternative cell source for tissue engineering of SM. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2979 / 2986
页数:8
相关论文
共 26 条
[1]  
Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO
[2]  
2-F
[3]   Lapine and canine bone marrow stromal cells contain smooth muscle actin and contract a collagen-glycosaminoglycan matrix [J].
Cai, DZ ;
Marty-Roix, R ;
Hsu, HP ;
Spector, M .
TISSUE ENGINEERING, 2001, 7 (06) :829-841
[4]   STROMAL CELLS FROM HUMAN LONG-TERM MARROW CULTURES ARE MESENCHYMAL CELLS THAT DIFFERENTIATE FOLLOWING A VASCULAR SMOOTH-MUSCLE DIFFERENTIATION PATHWAY [J].
GALMICHE, MC ;
KOTELIANSKY, VE ;
BRIERE, J ;
HERVE, P ;
CHARBORD, P .
BLOOD, 1993, 82 (01) :66-76
[5]  
GILDING DK, 1981, BIOCOMPATIBILITY CLI, P209
[6]   Fibrin as an alternative biopolymer to type-I collagen for the fabrication of a media equivalent [J].
Grassl, ED ;
Oegema, TR ;
Tranquillo, RT .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 2002, 60 (04) :607-612
[7]   Circulating bone marrow cells can contribute to neointimal formation [J].
Han, CL ;
Campbell, GR ;
Campbell, JH .
JOURNAL OF VASCULAR RESEARCH, 2001, 38 (02) :113-119
[8]   Origin of neointimal endothelium and α-actin-positive smooth muscle cells in transplant arteriosclerosis [J].
Hillebrands, JL ;
Klatter, FA ;
van den Hurk, BMH ;
Popa, ER ;
Nieuwenhuis, P ;
Rozing, J .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (11) :1411-1422
[9]   Tissue engineering of functional trileaflet heart valves from human marrow stromal cells [J].
Hoerstrup, SP ;
Kadner, A ;
Melnitchouk, S ;
Trojan, A ;
Eid, K ;
Tracy, J ;
Sodian, R ;
Visjager, JF ;
Kolb, SA ;
Grunenfelder, J ;
Zund, G ;
Turina, MI .
CIRCULATION, 2002, 106 (13) :I143-I150
[10]   A new source for cardiovascular tissue engineering: human bone marrow stromal cells [J].
Kadner, A ;
Hoerstrup, SP ;
Zund, G ;
Eid, K ;
Maurus, C ;
Melnitchouk, S ;
Grunenfelder, J ;
Turina, MI .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2002, 21 (06) :1055-1060